Edition:
United States

Deena Beasley

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

2:06am EDT

Express Scripts staking out million dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Aug 03 2018

Eisai/Biogen to advance Alzheimer's drug, provide fresh hope

(In this July 24th story, corrects paragraphs 3 and 16 to clarify that Eisai executive said the trial generated positive, rather than effective, results at lower doses)

Jul 26 2018

Amgen's new migraine drug hits insurance hurdles

Amgen Inc's push to get patients on its new $575 a month migraine drug before competition emerges in September is facing barriers from insurers.

Jul 24 2018

Focus: Eisai/Biogen to advance Alzheimer's drug, provide fresh hope

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.

Jul 07 2018

U.S. using DNA testing in effort to reunite families it separated

The U.S. government, under court order to quickly reunify parents and children who were separated after crossing illegally into the United States from Mexico, has expanded its use of DNA tests to establish paternity in immigration matters.

Jun 21 2018

Head of new U.S. corporate health plan cites surgery as biggest cost

San Diego Dr. Atul Gawande, a surgeon who was named this week to head the company being formed by Amazon, Berkshire Hathaway and JPMorgan Chase to trim employee healthcare costs, on Thursday cited surgery as the single biggest U.S. healthcare cost and said there are ways to both cut costs and improve patient care.

Jun 11 2018

Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO

LOS ANGELES Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told Reuters.

Jun 04 2018

U.S. FDA wants to shorten new drug monopolies to cut costs

CHICAGO In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.

Jun 03 2018

FDA wants to shorten new drug monopolies to cut costs

CHICAGO In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.

Jun 03 2018

Merck's Keytruda extends lung cancer survival in two trials

CHICAGO Merck & Co's immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous cell lung cancer, new data released on Sunday showed, further cementing the company's lead in the most lucrative oncology market.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary